Dyno Therapeutics Revenue and Competitors

Boston, MA USA

Location

$109M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Dyno Therapeutics's estimated annual revenue is currently $28.9M per year.(i)
  • Dyno Therapeutics's estimated revenue per employee is $193,750
  • Dyno Therapeutics's total funding is $109M.

Employee Data

  • Dyno Therapeutics has 149 Employees.(i)
  • Dyno Therapeutics grew their employee count by 3% last year.

Dyno Therapeutics's People

NameTitleEmail/Phone
1
Founder & CEOReveal Email/Phone
2
Co-founder & Executive ChairmanReveal Email/Phone
3
Head StewardshipReveal Email/Phone
4
Head BiologyReveal Email/Phone
5
VP, Head Corporate DevelopmentReveal Email/Phone
6
ControllerReveal Email/Phone
7
Head PlatformReveal Email/Phone
8
Head EngineeringReveal Email/Phone
9
Head Partner SuccessReveal Email/Phone
10
DirectorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is Dyno Therapeutics?

Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.

keywords:N/A

$109M

Total Funding

149

Number of Employees

$28.9M

Revenue (est)

3%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Dyno Therapeutics News

2022-04-17 - Undeterred by gene therapy's struggles, a startup launches ...

Gene therapy companies have been especially vulnerable to a public market ... Stride Bio, Affinia Therapeutics and Dyno Therapeutics,...

2022-04-17 - Astellas and University of Tokyo extend partnership to develop ...

The gene therapy vectors were developed leveraging Dyno's CapsidMap platform, which utilises artificial intelligence to quickly optimise AAV...

2022-04-17 - Astellas takes $170m charge as it drops DMD gene therapies -

Astellas' gene therapy programmes – largely stemming from its $3 ... by Dyno Therapeutics, designed to improve the safety of the vectors.

2021-05-07 - Dyno Therapeutics gets $100M in a16z-led round

Dyno Therapeutics, a biotech startup that's applying AI to gene therapy, has announced a $100 million Series A led by Andreessen Horowitz, with participation from new investors including Casdin Capital, GV, Obvious Ventures and Lux Capital. Existing backers Polaris Partners, CRV and KdT also par ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$24.6M1492%N/A
#2
$23.1M1496%N/A
#3
$15M149-10%N/A
#4
$36.1M1495%N/A
#5
$3.5M1507%N/A